[go: up one dir, main page]

ZA201000397B - Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates - Google Patents

Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates

Info

Publication number
ZA201000397B
ZA201000397B ZA201000397A ZA201000397A ZA201000397B ZA 201000397 B ZA201000397 B ZA 201000397B ZA 201000397 A ZA201000397 A ZA 201000397A ZA 201000397 A ZA201000397 A ZA 201000397A ZA 201000397 B ZA201000397 B ZA 201000397B
Authority
ZA
South Africa
Prior art keywords
aminodiols
oxazolidinone
related intermediates
preparing oxazolidine
oxazolidine
Prior art date
Application number
ZA201000397A
Other languages
English (en)
Inventor
James C Towson
Original Assignee
Invervet Internat B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40019364&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201000397(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Invervet Internat B V filed Critical Invervet Internat B V
Publication of ZA201000397B publication Critical patent/ZA201000397B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA201000397A 2007-07-25 2010-01-19 Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates ZA201000397B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95181607P 2007-07-25 2007-07-25

Publications (1)

Publication Number Publication Date
ZA201000397B true ZA201000397B (en) 2010-09-29

Family

ID=40019364

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201000397A ZA201000397B (en) 2007-07-25 2010-01-19 Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates

Country Status (15)

Country Link
US (1) US20100210851A1 (xx)
EP (1) EP2173726A2 (xx)
JP (1) JP2010534667A (xx)
KR (1) KR20100046217A (xx)
CN (1) CN101796037A (xx)
AR (1) AR068325A1 (xx)
AU (1) AU2008279308A1 (xx)
BR (1) BRPI0814581A2 (xx)
CA (1) CA2693922A1 (xx)
CL (1) CL2008002174A1 (xx)
PE (1) PE20090505A1 (xx)
RU (1) RU2010106607A (xx)
TW (1) TW200925153A (xx)
WO (1) WO2009015111A2 (xx)
ZA (1) ZA201000397B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY146351A (en) 2003-05-29 2012-08-15 Schering Plough Ltd Compositions for treating infection in cattle and swine
CN101600686A (zh) * 2006-12-13 2009-12-09 先灵-普劳有限公司 氯霉素、甲砜霉素及其类似物的水溶性前药
JP2011529895A (ja) 2008-07-30 2011-12-15 インターベツト・インターナシヨナル・ベー・ベー フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
JP2014513116A (ja) 2011-05-02 2014-05-29 ゾエティス・エルエルシー 抗菌剤として有用な新規セファロスポリン
CN108299330B (zh) * 2018-02-06 2021-02-12 桂林医学院 去氢枞酸噁唑烷酮衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
IT1237798B (it) * 1989-10-20 1993-06-17 Zambon Spa Processo per l'inversione stereochimica di (2s,3s)-2-ammino-3-fenil-1 ,3-propandioli nei corrispondenti enantiomeri (2r,3r).
IT1249048B (it) * 1991-02-21 1995-02-11 Zambon Spa Processo per la preparazione di trans-(5r)-2-ossazoline -2,4,5, trisostituite
US5663361A (en) * 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
US7126005B2 (en) * 2003-10-06 2006-10-24 Aurobindo Pharma Limited Process for preparing florfenicol
AU2006287696A1 (en) * 2005-09-07 2007-03-15 Schering-Plough Pty. Limited A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to Florfenicol

Also Published As

Publication number Publication date
CA2693922A1 (en) 2009-01-29
BRPI0814581A2 (pt) 2017-05-09
CN101796037A (zh) 2010-08-04
JP2010534667A (ja) 2010-11-11
WO2009015111A8 (en) 2010-03-04
CL2008002174A1 (es) 2008-11-21
WO2009015111A3 (en) 2009-03-26
US20100210851A1 (en) 2010-08-19
AR068325A1 (es) 2009-11-11
EP2173726A2 (en) 2010-04-14
RU2010106607A (ru) 2011-08-27
KR20100046217A (ko) 2010-05-06
WO2009015111A2 (en) 2009-01-29
PE20090505A1 (es) 2009-04-29
TW200925153A (en) 2009-06-16
AU2008279308A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
GB0715101D0 (en) Process
GB0711624D0 (en) Process
GB0706978D0 (en) Process
EP2123631A4 (en) PROCESS FOR PRODUCTION OF -ALCOXYPROPIONAMIDE
IL198117A0 (en) Process for preparing indol-5-oxy-quinazoline derivatives and intermediates
IL203761A (en) Process for Preparation of Compounds 4 - Aminobut - 2 - Anabolic, Intermediate and Initial Compounds
GB0716126D0 (en) Process
IL202228A0 (en) Process for preparing bepotastine and intermediates used therein
IL209919A0 (en) Process for preparing caspofungin and intermediates thereof
GB0714602D0 (en) Process
GB0711680D0 (en) Process
IL185627A (en) A process for making alkyl-anilides and their intermediates
GB0700074D0 (en) process
GB0715496D0 (en) Novel process
GB0714390D0 (en) Process
ZA201000397B (en) Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates
GB0724232D0 (en) Process
GB0716783D0 (en) New Process
GB0700878D0 (en) Process
GB201003018D0 (en) Process
GB0724716D0 (en) Process
ZA200907695B (en) Process for preparing dorzolam ide
IL195059A0 (en) Process for preparing duloxetine and intermediates thereof
IL183445A0 (en) Continuous process of preparing bromopicrin
GB0709689D0 (en) Process